Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Equivalence of Two Mometasone Nasal Sprays in Perennial Allergic Rhinitis
NCT01702103Phase 3Unknown
- Sponsor
- PHT Corporation
- Start
- Oct 2012
- Primary completion
- Jan 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of mometasone in perennial allergic rhinitis (PAR), sponsored by PHT Corporation. Status: unknown.
02
Drugs
mometasone
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT01702103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01702103.